<DOC>
	<DOC>NCT02338505</DOC>
	<brief_summary>Phase II prospective single-institutional study.</brief_summary>
	<brief_title>Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX</brief_title>
	<detailed_description>The aim of this Phase II prospective single-institutional study is to assess feasibility and early complications rate of Telelap ALF-X surgical treatment in obese patients affected by gynecological disease.</detailed_description>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Genital Diseases, Female</mesh_term>
	<criteria>informed consent 30 â‰¤ BMI &lt; 40 ASA &lt; III Ovarian Cyst Prophylactic bilateral salpingooophorectomy Ectopic Pregnancy Pelvic Inflammatory Disease Sterility/Infertility Benign uterine disease (fibromatosis, adenomyosis) Endometrial hiperplasia Earlystage Endometrial Cancer Preneoplastic lesions of the cervix IA1 Cervical Cancer Pelvic endometriosis Pregnancy Liver disease Coagulopathies Clinical conditions contraindicating laparoscopy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Robotic Surgery</keyword>
	<keyword>Telelap-ALFX</keyword>
	<keyword>Gynecological disease</keyword>
</DOC>